BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32325877)

  • 1. Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies.
    Nakliang P; Lazim R; Chang H; Choi S
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32325877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
    Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of multiscale simulations on GPCRs.
    Durdagi S; Dogan B; Erol I; Kayık G; Aksoydan B
    Curr Opin Struct Biol; 2019 Apr; 55():93-103. PubMed ID: 31082696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
    Li YY; Hou TJ; Goddard WA
    Curr Med Chem; 2010; 17(12):1167-80. PubMed ID: 20158474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Rhodopsin-Arrestin Interactions with the Fragment Molecular Orbital (FMO) Method.
    Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2020; 2114():177-186. PubMed ID: 32016894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
    Luginina AP; Khnykin AN; Khorn PA; Moiseeva OV; Safronova NA; Pospelov VA; Dashevskii DE; Belousov AS; Borschevskiy VI; Mishin AV
    Biochemistry (Mosc); 2024 May; 89(5):958-972. PubMed ID: 38880655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galaxy7TM: flexible GPCR-ligand docking by structure refinement.
    Lee GR; Seok C
    Nucleic Acids Res; 2016 Jul; 44(W1):W502-6. PubMed ID: 27131365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
    Lee Y; Lazim R; Macalino SJY; Choi S
    Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
    Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova.
    Ciancetta A; Cuzzolin A; Deganutti G; Sturlese M; Salmaso V; Cristiani A; Sabbadin D; Moro S
    Mol Inform; 2016 Sep; 35(8-9):440-8. PubMed ID: 27546048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of ligand type and receptor activation state.
    Thomas BN; Parrill AL; Baker DL
    J Mol Graph Model; 2022 May; 112():108119. PubMed ID: 34979368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.